Jung-Kyu Han
Overview
Explore the profile of Jung-Kyu Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang J, Chung J, Park K, Bae J, Lee H, Hwang D, et al.
JAMA Cardiol
. 2024 Nov;
PMID: 39602157
Importance: Antiplatelet monotherapy in the chronic maintenance period for patients with high bleeding risk (HBR) and those who have undergone complex percutaneous coronary intervention (PCI) has not yet been explored....
2.
Ahn H, Bruno F, Kang J, Hwang D, Yang H, Han J, et al.
Korean Circ J
. 2024 Nov;
55(1):5-16.
PMID: 39601395
Background And Objectives: The risk profiles, procedural characteristics, and clinical outcomes for women undergoing bifurcation percutaneous coronary intervention (PCI) are not well defined compared to those in men. Methods: COronary...
3.
Yun J, Han K, Ki Y, Hwang D, Kang J, Yang H, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518680
The impact of alcohol consumption and its restriction on clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) remains elusive. We aimed to investigate the clinical outcomes in drinkers undergoing...
4.
Han J, Lee S, Hwang D, Park S, Kang J, Yang H, et al.
Circ J
. 2024 Oct;
89(3):281-291.
PMID: 39401917
Background: The optimal duration of dual antiplatelet therapy (DAPT) in patients with chronic kidney disease undergoing percutaneous coronary intervention (PCI), especially with third-generation drug-eluting stents (DES), remains unknown. Methods And...
5.
Kang J, Park S, Park K, Koo B, Lee H, Han M, et al.
J Am Heart Assoc
. 2024 Sep;
13(18):e035269.
PMID: 39248265
Background: Clopidogrel monotherapy improved clinical outcomes compared with aspirin monotherapy during a chronic maintenance period in patients who underwent coronary stenting in the HOST-EXAM (Harmonizing Optimal Strategy for Treatment of...
6.
Han M, Kang J, Kwon S, Jeon J, You S, Hwang D, et al.
Can J Cardiol
. 2024 Aug;
40(11):2036-2044.
PMID: 39095015
Background: Transcatheter aortic valve implantation (TAVI) is preferred for treating severe aortic stenosis in older, frail populations, yet the impact of frailty on economic and clinical outcomes of TAVI is...
7.
Kang J, Yun J, Park K, Park M, Park S, Hwang D, et al.
Eur Heart J
. 2024 Jul;
45(36):3721-3731.
PMID: 39042715
Background And Aims: Patients with high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI) are at increased risk of not only bleeding, but also ischaemic events. This study aimed to...
8.
Kang J, Park S, Han M, Park K, Han J, Yang H, et al.
Korean Circ J
. 2024 Jul;
54(10):603-615.
PMID: 38956939
Background And Objectives: The clinical benefits of complete revascularization (CR) in acute myocardial infarction (AMI) patients are unclear. Moreover, the benefit of CR is unknown in AMI with diabetes mellitus...
9.
Kang J, Hwang D, Park K, Han J, Yang H, Kang H, et al.
EuroIntervention
. 2024 Jun;
20(12):e750-e759.
PMID: 38887886
Background: Long-term follow-up is essential to evaluate the impact of polymer degradation in drug-eluting stents (DES). Aims: We aimed to compare durable-polymer DES (DP-DES) and biodegradable-polymer DES (BP-DES) during a...
10.
Han J, Yang S, Hwang D, Park S, Kang J, Yang H, et al.
Circ Cardiovasc Interv
. 2024 May;
17(7):e013585.
PMID: 38786579
Background: The efficacy and safety of each third-generation drug-eluting stent with ultrathin struts and advanced polymer technology remain unclear. We investigated the clinical outcomes of percutaneous coronary intervention using the...